v3.26.1
SEGMENT REPORTING (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting [Line Items]    
Sales $ 113,771 $ 62,874
Cost of goods sold 45,156 45,156
Total operating expenses 3,983,259 4,074,702
Net (loss) gain from operations (3,914,644) (4,056,984)
Biotechnology [Member]    
Segment Reporting [Line Items]    
Sales 0 0
Cost of goods sold 0 0
Total operating expenses 3,870,396 4,014,702
Net (loss) gain from operations (3,870,396) (4,014,702)
Technology [Member]    
Segment Reporting [Line Items]    
Sales 113,771 62,874
Cost of goods sold 45,156 45,156
Total operating expenses 112,683 60,000
Net (loss) gain from operations $ (44,248) $ (42,282)